136 related articles for article (PubMed ID: 18331117)
1. Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system.
Kroner BA; Billups SJ; Garrison KM; Lyman AE; Delate T
J Manag Care Pharm; 2008 Mar; 14(2):155-63. PubMed ID: 18331117
[TBL] [Abstract][Full Text] [Related]
2. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
de Oliveira DR; Brummel AR; Miller DB
J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
[TBL] [Abstract][Full Text] [Related]
3. Medication therapy management: 10 years of experience in a large integrated health care system.
Ramalho de Oliveira D; Brummel AR; Miller DB
J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
5. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
6. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
[TBL] [Abstract][Full Text] [Related]
7. Economic and utilization outcomes of medication management at a large Medicaid plan with disease management pharmacists using a novel artificial intelligence platform from 2018 to 2019: a retrospective observational study using regression methods.
Kessler S; Desai M; McConnell W; Jai EM; Mebine P; Nguyen J; Kiroyan C; Ho D; Von Schweber E; Von Schweber L
J Manag Care Spec Pharm; 2021 Sep; 27(9):1186-1196. PubMed ID: 34032130
[No Abstract] [Full Text] [Related]
8. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
10. Impact of primary care intensive management on medication adherence and adjustments.
Yoon J; Wu F; Chang E
Am J Manag Care; 2020 Aug; 26(8):e239-e245. PubMed ID: 32835465
[TBL] [Abstract][Full Text] [Related]
11. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
12. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
[TBL] [Abstract][Full Text] [Related]
13. Labor costs and economic impact of a primary care clinical pharmacy service on postfracture care in postmenopausal women.
Irwin AN; Billups SJ; Heilmann RM
Pharmacotherapy; 2015 Mar; 35(3):243-50. PubMed ID: 25809175
[TBL] [Abstract][Full Text] [Related]
14. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
15. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
Kaur AD; McQueen A; Jan S
J Manag Care Pharm; 2008 Mar; 14(2):186-94. PubMed ID: 18331120
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan.
Wittayanukorn S; Westrick SC; Hansen RA; Billor N; Braxton-Lloyd K; Fox BI; Garza KB
J Manag Care Pharm; 2013 Jun; 19(5):385-95. PubMed ID: 23697476
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
20. Impact of a value-based formulary in three chronic disease cohorts.
Yeung K; Basu A; Marcum ZA; Watkins JB; Sullivan SD
Am J Manag Care; 2017 Mar; 23(3 Suppl):S46-S53. PubMed ID: 29648740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]